NPI: 1487619326 · SHIPROCK, NM 87420 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 04/20/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 04/20/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 34,826 | $462K |
| 2019 | 35,802 | $857K |
| 2020 | 35,162 | $675K |
| 2021 | 33,903 | $560K |
| 2022 | 26,744 | $760K |
| 2023 | 16,592 | $564K |
| 2024 | 10,473 | $374K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 61,793 | 5,355 | $3.81M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 67,466 | 3,582 | $173K |
| J1270 | Injection, doxercalciferol, 1 mcg | 29,674 | 2,561 | $97K |
| J1756 | Injection, iron sucrose, 1 mg | 13,866 | 3,801 | $84K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 853 | 521 | $33K |
| A4657 | Syringe, with or without needle, each | 5,258 | 4,581 | $32K |
| 83970 | 3,417 | 3,156 | $8K | |
| 82728 | 2,549 | 2,390 | $4K | |
| 83540 | 2,594 | 2,415 | $2K | |
| 83550 | 2,263 | 2,107 | $1K | |
| 82108 | 403 | 378 | $595.31 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 1,559 | 1,019 | $555.05 |
| 90747 | 63 | 61 | $227.93 | |
| G0008 | Administration of influenza virus vaccine | 266 | 248 | $206.12 |
| 90674 | 161 | 152 | $204.10 | |
| 90662 | 31 | 28 | $30.01 | |
| G0010 | Administration of hepatitis b vaccine | 59 | 59 | $14.36 |
| 85041 | 602 | 574 | $3.70 | |
| 85048 | 603 | 574 | $3.12 | |
| 90661 | 22 | 22 | $0.00 |